|
|||||
|
|
| P13K／AKT／mTOR信号通路在乳腺癌Her-2治疗耐药中的作用研究进展 | |
| 引用本文： | 马瑞金,杨宇. P13K／AKT／mTOR信号通路在乳腺癌Her-2治疗耐药中的作用研究进展[J]. 实用肿瘤学杂志, 2014, 0(4): 360-363 |
| 作者姓名： | 马瑞金 杨宇 |
| 作者单位： | 哈尔滨医科大学附属第二医院肿瘤内科,哈尔滨150086 |
| 摘 要： | Her-2靶向治疗是Her-2过表达乳腺癌治疗的重要组成部分，但Her-2靶向治疗的耐药严重影响了乳腺癌的治疗。研究证实乳腺癌Her-2靶向治疗出现耐药的过程中有P13K／AKT／mTOR信号通路的激活，因此对P13K／AKT／mTOR信号通路及以P13K／AKT／mTOR信号通路为靶点的药物研究对乳腺癌治疗具有重要意义。 |
| 关 键 词： | P13K AKT mTOR Her-2 乳腺肿瘤 靶向治疗 |
The research development of PI3K/AKT/mTOR signaling pathway in Her - 2 resistance for the treat- ment of breast cancer |
|
| MA Ruijin,YANG Yu. The research development of PI3K/AKT/mTOR signaling pathway in Her - 2 resistance for the treat- ment of breast cancer[J]. Journal of Practical Oncology, 2014, 0(4): 360-363 | |
| Authors: | MA Ruijin YANG Yu |
| Affiliation: | Department of Oncology ,The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China |
| Abstract: | Her -2 targeting therapy is an important part of the treatment for breast cancer with Her -2 overexpression. However, the therapeutic effectiveness is largely influenced by Her - 2 resistance. Previous studies have confirmed that PI3K/AKT/mTOR signaling pathway is activated during the process of drug resistance to Her -2- targeting therapy. Therefore, investigating the PI3K/AKT/mTOR signaling pathway and drugs -targeted pathway are important for the treatment of breast cancer. |
| Keywords: | PI3 K/AKT/mTOR pathway Her - 2 Breast neoplasms Targeted therapy |
| 本文献已被 维普 等数据库收录！ | |